nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced gene-editing strategy for epidermolysis bullosa simplex
|
Sheriff, Adam |
|
|
32 |
2 |
p. 271-272 |
artikel |
2 |
Allele-specific CRISPR-Cas9 editing of dominant epidermolysis bullosa simplex in human epidermal stem cells
|
Cattaneo, C. |
|
|
32 |
2 |
p. 372-383 |
artikel |
3 |
A new frontier: FDA approvals for gene therapy in sickle cell disease
|
Leonard, Alexis |
|
|
32 |
2 |
p. 264-267 |
artikel |
4 |
A new immune pathway mediating AAV immune responses
|
Chan, Ying Kai |
|
|
32 |
2 |
p. 269-270 |
artikel |
5 |
A replicating LCMV-based vaccine for the treatment of solid tumors
|
Purde, Mette-Triin |
|
|
32 |
2 |
p. 426-439 |
artikel |
6 |
ASC-expressing pyroptotic extracellular vesicles alleviate sepsis by protecting B cells
|
Huang, Weiying |
|
|
32 |
2 |
p. 395-410 |
artikel |
7 |
Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+ T cell activity
|
Luan, Xiaojin |
|
|
32 |
2 |
p. 469-489 |
artikel |
8 |
CTLA-4: Checkpoints beyond the membrane
|
Buchan, Sarah L. |
|
|
32 |
2 |
p. 279-281 |
artikel |
9 |
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression
|
Munoz, Ashlie M. |
|
|
32 |
2 |
p. 527-539 |
artikel |
10 |
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease
|
Yan, Jingyi |
|
|
32 |
2 |
p. 540-555 |
artikel |
11 |
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
|
Kokalaki, Evangelia |
|
|
32 |
2 |
p. 556-558 |
artikel |
12 |
Engineered mischarged transfer RNAs for correcting pathogenic missense mutations
|
Hou, Yichen |
|
|
32 |
2 |
p. 352-371 |
artikel |
13 |
Epicardial placement of human MSC-loaded fibrin sealant films for heart failure: Preclinical efficacy and mechanistic data
|
Fields, Laura |
|
|
32 |
2 |
p. 562 |
artikel |
14 |
Evolving membrane-associated accessory protein variants for improved adeno-associated virus production
|
Schieferecke, Adam J. |
|
|
32 |
2 |
p. 340-351 |
artikel |
15 |
Fighting fire with fire: Extracellular vesicles from pyroptotic mesenchymal stromal cells can dampen inflammation during sepsis
|
Ozkocak, Dilara C. |
|
|
32 |
2 |
p. 275-276 |
artikel |
16 |
Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors
|
Novaes, Gabriela Machado |
|
|
32 |
2 |
p. 440-456 |
artikel |
17 |
In this issue
|
|
|
|
32 |
2 |
p. 268 |
artikel |
18 |
In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition
|
Guo, Qi |
|
|
32 |
2 |
p. 384-394 |
artikel |
19 |
Irradiated engineered tumor cell-derived microparticles remodel the tumor immune microenvironment and enhance antitumor immunity
|
Hu, Yan |
|
|
32 |
2 |
p. 411-425 |
artikel |
20 |
Missense suppressor tRNA therapeutics correct disease-causing alleles by misreading the genetic code
|
Bily, Teija M.I. |
|
|
32 |
2 |
p. 273-274 |
artikel |
21 |
Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction
|
Qin, Yu-Yan |
|
|
32 |
2 |
p. 559-561 |
artikel |
22 |
Novel engineered recombinant ACE2 reduces SARS-CoV-2-induced COVID-19 without cardiotoxic side effects
|
Ávila-Moreno, Federico |
|
|
32 |
2 |
p. 282-283 |
artikel |
23 |
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
|
Mikkilineni, Lekha |
|
|
32 |
2 |
p. 503-526 |
artikel |
24 |
Shifting gears with CAR T cells for autoimmune diseases
|
Kale, Brandon |
|
|
32 |
2 |
p. 261-263 |
artikel |
25 |
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity
|
Kennedy, Paul T. |
|
|
32 |
2 |
p. 457-468 |
artikel |
26 |
Superantigen-fused T cell engagers for tumor antigen-mediated robust T cell activation and tumor cell killing
|
Zhao, Wen-Bin |
|
|
32 |
2 |
p. 490-502 |
artikel |
27 |
The landscape of nanoparticle-based siRNA delivery and therapeutic development
|
Moazzam, Muhammad |
|
|
32 |
2 |
p. 284-312 |
artikel |
28 |
Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs
|
Gu, Yue-Yu |
|
|
32 |
2 |
p. 313-324 |
artikel |
29 |
TLR9-independent CD8+ T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling
|
Kumar, Sandeep R.P. |
|
|
32 |
2 |
p. 325-339 |
artikel |
30 |
Uncovering mechanisms underlying complement-mediated cancer immune evasion
|
O'Connell, Patrick |
|
|
32 |
2 |
p. 277-278 |
artikel |